Medtronic’s Heart Device Unit May Ease Earnings Pressure From Omicron
By Amruta Khandekar (Reuters) – Steady sales of pacemakers and heart stents may have likely helped Medtronic Plc offset weak demand for its other medical devices, in a quarter that saw an Omicron-led surge in COVID-19 cases and staffing crisis at most U.S. hospitals. Overwhelmed by soaring infections and shortages of nurses and other healthcare…
